8501 ORAL Phase ll-trial of Concomitant Hyperfractionated-accelerated Radiotherapy (HART) With Cisplatin (Cis) Plus Cetuximab (Cet) for Locoregionally Advanced Inoperable Squamous Cell Head and Neck Cancer – Early Response and Acute Toxicities
Thomas Kuhnt(Leipzig University), Juergen Dunst(Martin Luther University Halle-Wittenberg), Peter Hass, A. Pirnasch(University of Rostock), Frank Sieker(Martin Luther University Halle-Wittenberg), Rita Engenhart‐Cabillic(Philipps University of Marburg), Matthias Hipp(University Hospital Regensburg), Andreas Schreiber(University of South Australia), K. Delias, Michael Richter(Technical University of Munich)
Cited by 0
Related Papers
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
|The Lancet Oncology|2012|505